Cross-Sector entity
Evotec is most often covered alongside Christiane Bardroff, which appears in 2 of these 4 stories. That works out to roughly 0.2 stories per week across a 159-day span. The busiest single day carried 2. Coverage clusters in pharma, which accounts for 3 of those 4, with the remainder spread across 1 other category.
4 verified stories tracked
Last mentioned: Jul 27, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Evotec is most often covered alongside Christiane Bardroff, which appears in 2 of these 4 stories. That works out to roughly 0.2 stories per week across a 159-day span. The busiest single day carried 2. Coverage clusters in pharma, which accounts for 3 of those 4, with the remainder spread across 1 other category. The tracked stories average 2.3 original sources each. Evotec appears in 4 tracked Cross-Sector stories published from February 19, 2026 through July 27, 2026.
Computed from the 4 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Evotec. Shared-story counts are live from our verified record — not editorial picks.
CBO Appointment
Christiane Bardroff is officially named Chief Business Officer to lead global commercial strategy.
Denmark Expansion
Company announces further $1.2 billion investment to double capacity at its Hillerød site.
Holly Springs Investment
Fujifilm announces $2 billion investment in a new large-scale cell culture facility in North Carolina.
A new DelveInsight forecast projects a 47% CAGR for the Alport syndrome market through 2036, fueled by a pipeline of gene and targeted therapies. The report highlights ELX-02 from Eloxx as a potential first-mover gene therapy with an 8-week dosing interval, while big pharma players like Bayer and Novartis advance competitors.
Source: prnewswire.com · finanznachrichten.de
FUJIFILM Biotechnologies has appointed industry veteran Christiane Bardroff as Chief Business Officer to lead its global commercial strategy. The move comes as the company nears the completion of multi-billion dollar manufacturing expansions in the United States and Europe.
FUJIFILM Biotechnologies has appointed industry veteran Christiane Bardroff as its new Chief Business Officer to lead global commercial strategy. The move comes as the CDMO giant continues a multi-billion dollar expansion of its manufacturing footprint across Europe and North America.
Source: finanznachrichten.de · pharmiweb.com
Halozyme Therapeutics reported a strong revenue beat of $451 million for the fourth quarter, driven by its ENHANZE platform royalties, yet surprised investors with a significant non-GAAP EPS miss of $2.44. The discrepancy suggests substantial one-time charges or strategic shifts that contrast with the company's robust top-line growth.
Source: Seeking Alpha · Seeking Alpha
